Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Cipla
Covington
Boehringer Ingelheim
Medtronic
Farmers Insurance

Generated: June 24, 2019

DrugPatentWatch Database Preview

Details for Patent: 8,685,442

Try a free trialSee Plans and Pricing

« Back to Dashboard

Which drugs does patent 8,685,442 protect, and when does it expire?

Patent 8,685,442 protects INBRIJA and is included in one NDA.

This patent has forty-seven patent family members in fourteen countries.

Summary for Patent: 8,685,442
Title:Capsules containing high doses of levodopa for pulmonary use
Abstract: The present invention provides a capsule containing an inhalable powder composition wherein the composition comprises about 75% by weight or more levodopa, dipalmitoylphosphatidylcholine (DPPC) and a salt characterized by a working density of less than about 100 g/L. The invention further provides a capsule containing an inhalable powder composition wherein the composition comprises about 75% by weight or more levodopa, dipalmitoylphosphatidylcholine (DPPC) and a salt characterized by a working density of less than about 100 g/L wherein the capsule material comprises hydroxypropylmethylcellulose (HPMC) and titanium dioxide.
Inventor(s): Batycky; Richard P. (Newton, MA), Lipp; Michael M. (Framingham, MA), Kamerkar; Abhijit (Boston, MA), Penachio; Ernest D. (Haverhill, MA), Kee; Kevin D. (Somerville, MA)
Assignee: Civitas Therapeutics, Inc. (Chelsea, MA)
Application Number:13/945,160
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 8,685,442
Patent Claim Types:
see list of patent claims
Compound; Device; Dosage form;

Drugs Protected by US Patent 8,685,442

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Acorda INBRIJA levodopa POWDER;INHALATION 209184-001 Dec 21, 2018 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Daiichi Sankyo
Argus Health
Johnson and Johnson
Farmers Insurance
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.